SEC Form 4 · accession 0000921895-17-001060
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giri Devanur
Officer — President & CEO
Period of report
Apr 11, 2017
Accepted (ET)
Apr 14, 2017 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 11, 2017 | A | 100 | — | A | 2,179,225 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Plan.